ACTA1 and hepatocellular carcinoma: At present, while there is still no effective treatment for recurrence of HCC after LT and also from the viewpoint of proliferation of α-SMA-positive CAF, LT, in particular LDLT, should be limited to recipients who are within Up-to-7 criteria in pre-operative imaging diagnosis.